The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Patterson Companies Inc

Nasdaq: PDCO
Last

(U.S.) $44.62

Today's change-0.22 -0.49%
Updated September 4 11:04 AM EDT. Delayed by at least 15 minutes.
 

Patterson Companies Inc

Nasdaq: PDCO
Last

(U.S.) $44.62

Today's change-0.22 -0.49%
Updated September 4 11:04 AM EDT. Delayed by at least 15 minutes.

Patterson Companies Inc down (U.S.)$0.22

Patterson Companies Inc is lower today, dropping (U.S.)$0.22 or 0.49% to (U.S.)$44.62. Over the last five days, shares have lost 3.82% and are down 7.23% for the last year to date. This security has outperformed the S&P 500 by 14.64% during the last year.

Key company metrics

  • Open(U.S.) $44.44
  • Previous close(U.S.) $44.84
  • High(U.S.) $44.82
  • Low(U.S.) $44.09
  • Bid / Ask(U.S.) $44.60 / (U.S.) $44.63
  • YTD % change-7.23%
  • Volume160,468
  • Average volume (10-day)1,912,196
  • Average volume (1-month)1,288,663
  • Average volume (3-month)1,004,460
  • 52-week range(U.S.) $39.28 to (U.S.) $53.07
  • Beta0.78
  • Trailing P/E22.99×
  • P/E 1 year forward18.23×
  • Forward PEG1.66×
  • Indicated annual dividend(U.S.) $0.88
  • Dividend yield1.97%
  • Trailing EPS(U.S.) $1.94
Updated September 4 11:04 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+4.34%

Based on its net profit margin of 4.34%, Patterson Companies Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.88%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedAug 01, 201508/01/2015Apr 25, 201504/25/2015Jan 24, 201501/24/2015Oct 25, 201410/25/2014
Revenue1,1431,1491,0631,103
Total other revenue--------
Total revenue1,1431,1491,0631,103
Gross profit288334303306
Total cost of revenue855815761798
Total operating expense1,0811,0429731,012
Selling / general / administrative--------
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total226227212215
Operating income621079191
Interest income (expense), net non-operating---8-9-9
Gain (loss) on sale of assets--------
Other--------
Income before tax51998383
Income after tax20655554
Income tax, total30352830
Net income30655554
Total adjustments to net income--------
Net income before extra. items20655554
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items20655554
Inc. avail. to common incl. extra. items30655554
Diluted net income30655554
Dilution adjustment00--0
Diluted weighted average shares10010010099
Diluted EPS excluding extraordinary itemsvalue per share0.200.650.550.54
Dividends per sharevalue per share0.220.220.200.20
Diluted normalized EPSvalue per share0.200.650.550.54